Stroke ranks as the second leading cause of death globally, trailing only heart disease. A breakthrough in...
Drugs
Knight Therapeutics Inc., a specialty pharmaceutical firm, has revealed that its New Drug Submission (NDS) for CREXONT®...
Solid Biosciences Inc., a clinical-stage leader in precision genetic medicines for neuromuscular and cardiac disorders, has secured...
AB Science SA, a pharmaceutical company focused on developing protein kinase inhibitors, has received authorization from Spain,...
